FITC Plus Anti-Human HLA-DR (L243)
HLA-DR Monoclonal Antibody for FC
Host / Isotype
Mouse / IgG2a, kappa
Reactivity
Human and More (1)
Applications
FC
Conjugate
FITC Plus Fluorescent Dye
CloneNo.
L243
验证数据展示
经过测试的应用
Positive FC detected in | human PBMCs |
推荐稀释比
Application | Dilution |
---|---|
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 μl per 10^6 cells in a 100 µl suspension or 5 μl per 100 µl of whole blood. | |
Sample-dependent, Check data in validation data gallery. |
发表文章中的应用
FC | See 2 publications below |
产品信息
FITC-65218 targets HLA-DR in FC applications and shows reactivity with Human samples.
Tested Applications | FC Application Description |
Cited Applications | FC |
Tested Reactivity | Human |
Cited Reactivity | human |
Immunogen | Human lymphoblastoid B-cell line RPMI 8866 种属同源性预测 |
Host / Isotype | Mouse / IgG2a, kappa |
Class | Monoclonal |
Type | Antibody |
Full Name | major histocompatibility complex, class II, DR alpha |
Synonyms | HLA DRA, HLA DRB, HLA-DR, HLA-DRA, HLA-DRB, MHC class II antigen DR |
Calculated Molecular Weight | 254 aa, 29 kDa |
GenBank Accession Number | BC032350 |
Gene Symbol | HLA-DRA |
Gene ID (NCBI) | 3122 |
ENSEMBL Gene ID | ENSG00000204287 |
Conjugate | FITC Plus Fluorescent Dye |
Excitation/Emission Maxima Wavelengths | 495 nm / 524 nm |
Form | Liquid |
Purification Method | Protein A purification |
UNIPROT ID | P01903 |
Storage Buffer | PBS with 0.09% sodium azide and 0.5% BSA. |
Storage Conditions | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
实验方案
Product Specific Protocols | |
---|---|
FC protocol for FITC Plus HLA-DR antibody FITC-65218 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
发表文章
Species | Application | Title |
---|---|---|
Cells Exosomes from Human Omental Adipose-Derived Mesenchymal Stem Cells Secreted into Ascites Promote Peritoneal Metastasis of Epithelial Ovarian Cancer | ||
Front Immunol Profiling hypoxia signaling reveals a lncRNA signature contributing to immunosuppression in high-grade glioma |